Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Moderna, Inc.

< Previous 1 2 3 4 5 6 Next >
News headline image
Moderna Submits Amendment to the Emergency Use Authorization for an Additional Booster Dose of its COVID-19 Vaccine in the U.S.
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Health Canada Authorizes Moderna's COVID-19 Vaccine in Children (6-11 Years)
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna and the Japanese Government Reach an Agreement to Supply Japan with Additional 70 Million Doses of Moderna's COVID-19 Booster Vaccine
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA Vaccine
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna to Host Third Annual Virtual Vaccines Day on March 24, 2022
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces Its Global Public Health Strategy
From Moderna, Inc.
Via AccessWire
Topics Intellectual Property
Tickers MRNA
News headline image
Moderna Announces Memorandum of Understanding with the Government of the Republic of Kenya to Establish its First mRNA Manufacturing Facility in Africa
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces Establishment of Enterprise Solutions Hub in Atlanta, Georgia
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna to Present at Upcoming Conferences in March 2022
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Expands Global Footprint Through Commercial Partnership with Adium in Latin America
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Initiates Phase 3 Portion of Pivotal Trial for mRNA Respiratory Syncytial Virus (RSV) Vaccine Candidate, Following Independent Safety Review of Interim Data
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Expands Its mRNA Pipeline with Three New Development Programs
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces Plan to Expand Commercial Footprint in Europe Across Six Additional Countries
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Chief Technical Operations and Quality Officer Juan Andres Elected to National Academy of Engineering
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces New Supply Agreement with Colombia for Additional 10.8 Million Doses of Moderna's COVID-19 Vaccine
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster Candidate and Publication of Data on Booster Durability Against Omicron Variant
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna Announces First Participant Dosed in Phase 1 Study of its mRNA Epstein-Barr Virus (EBV) Vaccine
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna to Present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
From Moderna, Inc.
Via AccessWire
Tickers MRNA
News headline image
Moderna to Provide Business and Pipeline Updates at the 2022 J.P. Morgan Healthcare Conference
From Moderna, Inc.
Via AccessWire
Tickers MRNA
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.